Viazov S O, Vlasikhina E M, Margolina A N, Favorov M O, Poverennyĭ A M
Vopr Virusol. 1985 May-Jun;30(3):324-7.
The results of trials of a subunit vaccine against hepatitis B in volunteers are presented. The active substance of the vaccine was HBsAg isolated from the plasma of asymptomatic antigen carriers. The preparation under study is highly immunogenic, shows poor reactogenicity, and safety in use.
本文展示了一种针对乙型肝炎的亚单位疫苗在志愿者身上的试验结果。该疫苗的活性物质是从无症状抗原携带者血浆中分离出的乙肝表面抗原（HBsAg）。所研究的制剂具有高度免疫原性，反应原性低，使用安全。
